Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01322230 · ClinicalTrials.gov registry record · NA
Trial of Educational Outcomes of WISE-MD
A NA study, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 1,363
- Enrollment target
NCT01322230: Completed NA study, sponsored by NYU Langone Health.
NCT01322230 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 1,363 participants, roughly in line with the 1,404-participant average among 58,714 other NA trials with a reported enrollment target. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01322230, a NA study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,363 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the educational efficacy of instructional design enhancements in on-line learning modules in the context of clinical medical education.
Primary Outcome
An 8 week-long Surgery Clerkship (Jefferson University is 12 weeks) occurs 6 times (JU 4 times) per year. Students enroll on day 1, complete the baseline surveys in week 1, access the intervention modules by week 2. Learning outcomes (knowledge test) are measured immediately after the modules, at week 4 they complete online multiple-choice tests and a clinical reasoning measure, week 8, week 12 at JU, students complete a clinical reasoning measure.
Interventions
- OTHER Control
- OTHER WISEMD Original
- OTHER Social Networking
- OTHER Social Networking plus Emotional Design
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,363 participants |
| Start Date | 2008-10 |
| Est. Completion | 2011-09 |
| Phase | NA |
What the finished NCT01322230 record still lists
NCT01322230 is an interventional study that assigns participants to a tested intervention. Its 1,363 participants enrollment target places it among the larger protocols in the corpus, roughly in line with the 1,404-participant average among 58,714 other NA trials with a reported enrollment target.
The record links to 0 conditions, and to 4 interventions - of which Control is the first listed.
NCT01322230 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01322230 about?
NCT01322230 is a clinical study titled "Trial of Educational Outcomes of WISE-MD". The purpose of this study is to compare the educational efficacy of instructional design enhancements in on-line learning modules in the context of clinical medical education.
What is the current status of trial NCT01322230?
This trial is currently completed. It is a NA study. The enrollment target is 1,363 participants. The study started on 2008-10. Estimated completion is 2011-09.
What interventions are being tested in trial NCT01322230?
The interventions under investigation include: Control (OTHER), WISEMD Original (OTHER), Social Networking (OTHER), Social Networking plus Emotional Design (OTHER).
Who is sponsoring clinical trial NCT01322230?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01322230's enrollment target sits among peer trials
1,363 73rd of 2000 higher than 1,928 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02677064 · 1,365 participants
Identify Barriers to Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Newly Diagnosed and Relapsed Acute Leukemia
- NCT04489238 · 1,366 participants
Collection of Information to Better Understand Young Onset Colorectal Cancer
- NCT05245227 · 1,358 participants · Phase 3
Double Simultaneous Uterotonic Agents Versus Single Agent Regimen to Prevent Early Postpartum Hemorrhage
- NCT07256392 · 1,370 participants · Phase 3
Long-term Efficacy and Safety Extension (LTE) Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia